SurModics (SRDX) Misses Q2 EPS by 4c, provides guidance
Tweet
Share
E-mailGet Alerts SRDX Hot Sheet
Price: $42.98 --0%
Financial Fact:
Income tax benefit (provision): -1.46M
Today's EPS Names:
AFIB, VAXX, NMRD, More
Financial Fact:
Income tax benefit (provision): -1.46M
Today's EPS Names:
AFIB, VAXX, NMRD, More
Join SI Premium – FREE
SurModics (NASDAQ: SRDX) reported Q2 EPS of ($0.13), $0.04 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $28.1 million versus the consensus estimate of $33.19 million.
GUIDANCE:
SurModics sees FY2025 EPS of ($0.62)-($0.42), versus the consensus of ($0.26). SurModics sees FY2025 revenue of $114-117 million, versus the consensus of $127.3 million.
For earnings history and earnings-related data on SurModics (SRDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paysafe Limited (PSFE) Misses Q2 EPS by 43c; offers guidance
- H.C. Wainwright Reiterates Neutral Rating on CalciMedica (CALC)
- SBC Medical Group Holdings Incorporated (SBC) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
